House Dust Mite Allergen: Clinical Trials

2 trials of House Dust Mite Allergen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 11Withdrawn 1
Phase 21Withdrawn 1

Follow House Dust Mite Allergen: new trials by email Literature Review of House Dust Mite Allergen trials Research Report on House Dust Mite Allergen

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis Patients
House Dust Mite Allergen, Allergen-free air - Atopic Dermatitis, House Dust Mite Allergy
Not applicableCompletedFraunhofer-Institute of Toxicology and Experimental Medicine232021-09-102024-10-15
Anakinra as a Rescue Treatment for Allergic Inflammation
Anakinra, Preservative-free 0.9% sodium chloride (Placebo), House dust mite allergen - Asthma, Allergic
Phase 1 / Phase 2WithdrawnUniversity of North Carolina, Chapel Hill2019-12-162022-06-08

Conditions studied

Asthma (1)  ·  Dermatitis, Atopic (1)  ·  Dust Mite Allergy (1)

Sponsors

Fraunhofer-Institute of Toxicology and Experimental Medicine (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

Germany (1)

Top investigators

Jens M Hohlfeld, Prof. Dr. (1)  ·  Michelle Hernandez (1)

NIH funding

R01HL135235 (1)